Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amnion Membrane Powder for Enhanced Wound Healing of Mohs Surgery Wound Sites
NCT07680023Phase 1Not yet recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- May 2027
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial of amnion membrane powder in surgical wound (2 arms), sponsored by Wake Forest University Health Sciences. Primary endpoints: Number of Participants with Infection at 16 weeks, Number of Participants with Allergic Reaction at 16 weeks and 3 more. Planned start May 2027; status: not yet recruiting.
02
Drugs
amnion membrane powder
03
Conditions
surgical wound
Beyond the preview
Go deeper on NCT07680023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07680023.